Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Tiotropium Bromide DPI vs Spiriva in COPD Maintenance Therapy
CTR20223185Phase 3Completed
- Sponsor
- Omni Pharmaceutical
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), emphysema, sponsored by Omni Pharmaceutical. Started Dec 2022; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)emphysema
Beyond the preview
Go deeper on CTR20223185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223185.